Inhibiting PP2A Upregulates B7-H3 Expression and Potentially Increases the Sensitivity of Malignant Meningiomas to Immunotherapy by Proteomics
Malignant meningiomas have a high mortality rate and short survival time and currently have no effective treatment. In our study, proteomics analysis was performed to identify highly expressed proteins as therapeutic targets in malignant meningiomas. Cell Counting Kit-8 (CCK-8) assays were performed...
Saved in:
Main Authors: | Boyi Hu (Author), Shuyu Hao (Author), Yazhou Miao (Author), Yuxuan Deng (Author), Jing Wang (Author), Hong Wan (Author), Shaodong Zhang (Author), Nan Ji (Author), Jie Feng (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Papillary meningioma: a rare but distinct variant of malignant meningioma
by: Shruti Sharma, et al.
Published: (2007) -
Papillary meningioma: A rare malignant variant
by: Zeeba Jairajpuri, et al.
Published: (2011) -
Meningioma anaplásico Anaplastic meningioma
by: Arlines Alina Piña Tornés, et al.
Published: (2013) -
IMMUNOHISTOCHEMICAL EXPRESSION OF MMP-9 AND VEGF IN BENIGN AND MALIGNANT BRAIN MENINGIOMAS
by: W. Voteva, et al.
Published: (2015) -
Immunohistochemical peculiarities of cell adhesion molecules distribution in benign and malignant brain meningiomas
by: W. E. Voteva, et al.
Published: (2014)